Dominique P. Monnet was appointed to the position of president of PDL BioPharma Inc.
One Drop, a digital diabetes care and self-management platform, announced a multi-part collaboration with Fitbit that will use the power of Fitbit wearable data to bring enhanced data-driven care management tools to the diabetes community.
A DRG Digital – Manhattan Research study of 189 U.S. P&T committee members making formulary decisions at hospitals, IDNs, PBMs, MCOs and ACOs found that on average, these key professionals spend upwards of three hours per day using digital resources to inform their committee work.
Nearly 3 in 10 – 29 percent – of total U.S. health care payments were tied to alternative payment models in 2016, compared to 23 percent in 2015, according to a report by the Health Care Payment Learning & Action Network. The public-private partnership was launched in March 2015 to drive adoption and alignment of APMs.
Two have been around in the pharmaceutical industry for a long time, and one is a relative newcomer. In considering this year’s pharma innovators to profile, the results of their accomplishments, not how long they have been around, steered the direction of this feature. Donna Murphy, global CEO of the recently formed agency network Havas Health & You; Abraham Gutman, president and CEO of AG Mednet; and C. David Nicholson, executive VP and chief R&D officer of Allergan, are being saluted for bringing new innovations to the fields of pharmaceutical advertising, clinical trial imaging and R&D, and their accomplishments are expected to echo into the future.
Just like 2016 and the year before, specialty drugs dominate the 2017 list of top performers in the most recent first year after launch class.
Med Ad News asked Adrienne Morgan and Geetiksa Prasad, the account and copy leads for Ibrance at H4B Chelsea, about their agency’s work with Pfizer’s star breast cancer brand.
The good news … is that innovation is addressing diseases with high-unmet need such as oncology, autoimmune diseases, and central nervous system (CNS) disorders. But, there is a complicating factor in the economic story: the patient population benefiting from launch brands is becoming smaller.
A listing of the the new molecular entities launched in the United States during 2015 that generated 2016 sales of at least $200 million
Med Ad News announces the 28th Annual Manny Awards nominees; FCB Health CEO/President Dana Maiman named ad industry Person of the Year.